Showing results (1891-1900 of 1,954) with videos related to

Sort By:
Pageof 196
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 25, 2019
Pathogenic variants in the DEAH-box RNA helicase DHX37 are a frequent cause of 46,XY gonadal dysgenesis and 46,XY testicular regression syndromeKen McElreavey, Anne Jorgensen, Caroline Eozenou, et al.
BMC Public Health|November 29, 2023
Associations between changes in habitual sleep duration and lower self-rated health among COVID-19 survivors: findings from a survey across 16 countries/regionsKentaro Matsui, Frances Chung, Adrijana Koscec Bjelajac, et al.
Heart Rhythm|June 7, 2026
Outcomes of left atrial appendage closure versus oral anticoagulation after catheter ablation among patients with higher and lower stroke risk: A sub-analysis of the OPTION clinical trialJeff S Healey, Rahul Doshi, Devi G Nair, et al.
Nature|April 24, 2024
Emx2 underlies the development and evolution of marsupial gliding membranesJorge A Moreno, Olga Dudchenko, Charles Y Feigin, et al.
The Pediatric Infectious Disease Journal|May 20, 2026
SARS-CoV-2 Reinfection and Risk of Multisystem Inflammatory Syndrome in Children: A Case-Control StudyNoémie Schiever, Léa Lenglart, Corinne Levy, et al.
Nature|April 6, 2022
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammationCaroline Junqueira, Ângela Crespo, Shahin Ranjbar, et al.
Archives of Dermatology|July 18, 2012
Prognostic factors of paraneoplastic pemphigusSandy Leger, Damien Picard, Saskia Ingen-Housz-Oro, et al.
Endoscopy|April 12, 2017
Adenoma detection with blue-water infusion colonoscopy: a randomized trialAdriane Lesne, Olivier Rouquette, Sandrine Touzet, et al.
Cell Reports|August 1, 2023
Genome-wide association studies of human and rat BMI converge on synapse, epigenome, and hormone signaling networksSarah N Wright, Brittany S Leger, Sara Brin Rosenthal, et al.
The European Respiratory Journal|May 25, 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trialJulie Mankikian, Agnès Caille, Martine Reynaud-Gaubert, et al.
Pageof 196